| Year |
Citation |
Score |
| 2018 |
Tripathi R, Liu Z, Plattner R. EnABLing Tumor Growth and Progression: Recent progress in unraveling the functions of ABL kinases in solid tumor cells. Current Pharmacology Reports. 4: 367-379. PMID 30746323 DOI: 10.1007/S40495-018-0149-Y |
0.358 |
|
| 2018 |
Tripathi R, Plattner R. EnABLing Cathepsin-Driven Melanoma Metastasis. Molecular & Cellular Oncology. 5: e1458016. PMID 30250913 DOI: 10.1080/23723556.2018.1458016 |
0.423 |
|
| 2018 |
Tripathi R, Fiore LS, Richards DL, Yang Y, Liu J, Wang C, Plattner R. Abl and Arg mediate cysteine cathepsin secretion to facilitate melanoma invasion and metastasis. Science Signaling. 11. PMID 29463776 DOI: 10.1126/Scisignal.Aao0422 |
0.461 |
|
| 2017 |
Jain A, Tripathi R, Turpin CP, Wang C, Plattner R. Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma. Oncogene. PMID 28368422 DOI: 10.1038/Onc.2017.76 |
0.488 |
|
| 2014 |
Baldwin LA, Hoff JT, Lefringhouse J, Zhang M, Jia C, Liu Z, Erfani S, Jin H, Xu M, She QB, van Nagell JR, Wang C, Chen L, Plattner R, Kaetzel DM, et al. CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling. Oncotarget. 5: 12203-17. PMID 25356755 DOI: 10.18632/Oncotarget.2622 |
0.324 |
|
| 2014 |
Fiore LS, Ganguly SS, Sledziona J, Cibull ML, Wang C, Richards DL, Neltner JM, Beach C, McCorkle JR, Kaetzel DM, Plattner R. c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer. Oncogene. 33: 4508-20. PMID 24096484 DOI: 10.1038/Onc.2013.399 |
0.665 |
|
| 2014 |
Zhao H, Chen MS, Lo YH, Waltz SE, Wang J, Ho PC, Vasiliauskas J, Plattner R, Wang YL, Wang SC. The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer. Oncogene. 33: 1429-37. PMID 23542172 DOI: 10.1038/Onc.2013.84 |
0.534 |
|
| 2013 |
Sims JT, Ganguly SS, Bennett H, Friend JW, Tepe J, Plattner R. Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1. Plos One. 8: e55509. PMID 23383209 DOI: 10.1371/Journal.Pone.0055509 |
0.679 |
|
| 2013 |
Ganguly SS, Fiore LS, Sims JT, Friend JW, Srinivasan D, Thacker M, Cibull ML, Chi W, Plattner R. Abstract C51: c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion, proliferation, survival, and drive metastatic progression Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C51 |
0.748 |
|
| 2012 |
Ganguly SS, Plattner R. Activation of abl family kinases in solid tumors. Genes & Cancer. 3: 414-25. PMID 23226579 DOI: 10.1177/1947601912458586 |
0.702 |
|
| 2012 |
Ganguly SS, Fiore LS, Sims JT, Friend JW, Srinivasan D, Thacker MA, Cibull ML, Wang C, Novak M, Kaetzel DM, Plattner R. c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression. Oncogene. 31: 1804-16. PMID 21892207 DOI: 10.1038/Onc.2011.361 |
0.741 |
|
| 2010 |
Zhao H, Ou-Yang F, Chen IF, Hou MF, Yuan SS, Chang HL, Lee YC, Plattner R, Waltz SE, Ho SM, Sims J, Wang SC. Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer. Neoplasia (New York, N.Y.). 12: 214-23. PMID 20234815 DOI: 10.1593/Neo.91576 |
0.388 |
|
| 2009 |
Sims JT, Ganguly S, Fiore LS, Holler CJ, Park ES, Plattner R. STI571 sensitizes breast cancer cells to 5-fluorouracil, cisplatin and camptothecin in a cell type-specific manner. Biochemical Pharmacology. 78: 249-60. PMID 19427998 DOI: 10.1016/J.Bcp.2009.04.007 |
0.655 |
|
| 2009 |
Sims JT, Plattner R. MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell lines. Cancer Chemotherapy and Pharmacology. 64: 629-33. PMID 19396599 DOI: 10.1007/S00280-009-1004-Y |
0.456 |
|
| 2009 |
Srinivasan D, Kaetzel DM, Plattner R. Reciprocal regulation of Abl and receptor tyrosine kinases. Cellular Signalling. 21: 1143-50. PMID 19275932 DOI: 10.1016/J.Cellsig.2009.03.003 |
0.637 |
|
| 2008 |
Mitra S, Beach C, Feng GS, Plattner R. SHP-2 is a novel target of Abl kinases during cell proliferation. Journal of Cell Science. 121: 3335-46. PMID 18827006 DOI: 10.1242/Jcs.035691 |
0.485 |
|
| 2008 |
Srinivasan D, Sims JT, Plattner R. Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival. Oncogene. 27: 1095-105. PMID 17700528 DOI: 10.1038/Sj.Onc.1210714 |
0.666 |
|
| 2006 |
Srinivasan D, Plattner R. Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells. Cancer Research. 66: 5648-55. PMID 16740702 DOI: 10.1158/0008-5472.Can-06-0734 |
0.686 |
|
| 2004 |
Plattner R, Koleske AJ, Kazlauskas A, Pendergast AM. Bidirectional signaling links the Abelson kinases to the platelet-derived growth factor receptor. Molecular and Cellular Biology. 24: 2573-83. PMID 14993293 DOI: 10.1128/Mcb.24.6.2573-2583.2004 |
0.707 |
|
| 2003 |
Burton EA, Plattner R, Pendergast AM. Abl tyrosine kinases are required for infection by Shigella flexneri. The Embo Journal. 22: 5471-9. PMID 14532119 DOI: 10.1093/Emboj/Cdg512 |
0.668 |
|
| 2003 |
Plattner R, Pendergast AM. Activation and signaling of the Abl tyrosine kinase: bidirectional link with phosphoinositide signaling. Cell Cycle (Georgetown, Tex.). 2: 273-4. PMID 12851468 DOI: 10.4161/Cc.2.4.409 |
0.638 |
|
| 2003 |
Plattner R, Irvin BJ, Guo S, Blackburn K, Kazlauskas A, Abraham RT, York JD, Pendergast AM. A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma1. Nature Cell Biology. 5: 309-19. PMID 12652307 DOI: 10.1038/Ncb949 |
0.7 |
|
| 2001 |
Gupta S, Stuffrein S, Plattner R, Tencati M, Gray C, Whang YE, Stanbridge EJ. Role of phosphoinositide 3-kinase in the aggressive tumor growth of HT1080 human fibrosarcoma cells Molecular and Cellular Biology. 21: 5846-5856. PMID 11486024 DOI: 10.1128/Mcb.21.17.5846-5856.2001 |
0.558 |
|
| 2000 |
Gupta S, Plattner R, Der CJ, Stanbridge EJ. Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: Evidence for a potential novel pathway Molecular and Cellular Biology. 20: 9294-9306. PMID 11094080 DOI: 10.1128/Mcb.20.24.9294-9306.2000 |
0.625 |
|
| 2000 |
Johnsen JI, Aurelio ON, Kwaja Z, Jörgensen GE, Pellegata NS, Plattner R, Stanbridge EJ, Cajot JF. p53-Mediated negative regulation of stathmin/Op18 expression is associated with G2/M cell-cycle arrest International Journal of Cancer. 88: 685-691. PMID 11072234 DOI: 10.1002/1097-0215(20001201)88:5<685::Aid-Ijc1>3.0.Co;2-Z |
0.478 |
|
| 1999 |
Plattner R, Kadlec L, DeMali KA, Kazlauskas A, Pendergast AM. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes & Development. 13: 2400-11. PMID 10500097 DOI: 10.1101/Gad.13.18.2400 |
0.734 |
|
| 1999 |
Plattner R, Gupta S, Khosravi-Far R, Sato KY, Perucho M, Der CJ, Stanbridge EJ. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells Oncogene. 18: 1807-1817. PMID 10086335 DOI: 10.1038/Sj.Onc.1202482 |
0.637 |
|
| 1996 |
Plattner R, Anderson MJ, Sato KY, Fasching CL, Der CJ, Stanbridge EJ. Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. Proceedings of the National Academy of Sciences of the United States of America. 93: 6665-70. PMID 8692875 DOI: 10.1073/Pnas.93.13.6665 |
0.571 |
|
| 1994 |
Leana-Cox J, Jenkins L, Palmer CG, Plattner R, Sheppard L, Flejter WL, Zackowski J, Tsien F, Schwartz S. Molecular cytogenetic analysis of inv dup(15) chromosomes, using probes specific for the Prader-Willi/Angelman syndrome region: clinical implications. American Journal of Human Genetics. 54: 748-56. PMID 8178816 |
0.523 |
|
| 1993 |
Plattner R, Heerema NA, Yurov YB, Palmer CG. Efficient identification of marker chromosomes in 27 patients by stepwise hybridization with alpha-satellite DNA probes Human Genetics. 91: 131-140. PMID 8462972 DOI: 10.1007/Bf00222713 |
0.519 |
|
| 1993 |
Plattner R, Heerema NA, Howard-Peebles PN, Miles JH, Soukup S, Palmer CG. Clinical findings in patients with marker chromosomes identified by fluorescence in situ hybridization. Human Genetics. 91: 589-98. PMID 8340114 DOI: 10.1007/Bf00205086 |
0.518 |
|
| 1991 |
Plattner R, Heerema NA, Patil SR, Howard-Peebles PN, Palmer CG. Characterization of seven DA/DAPI-positive bisatellited marker chromosomes by in situ hybridization. Human Genetics. 87: 290-6. PMID 1864603 DOI: 10.1007/Bf00200906 |
0.528 |
|
| 1989 |
Fekete G, Plattner R, Crabb DW, Zhang B, Harris RA, Heerema N, Palmer CG. Localization of the human gene for the El alpha subunit of branched chain keto acid dehydrogenase (BCKDHA) to chromosome 19q13.1----q13.2. Cytogenetics and Cell Genetics. 50: 236-7. PMID 2805821 DOI: 10.1159/000132768 |
0.517 |
|
| 1988 |
Milatovich A, Plattner R, Heerema NA, Palmer CG, Lopez-Casillas F, Kim KH. Localization of the gene for acetyl-CoA carboxylase to human chromosome 17. Cytogenetics and Cell Genetics. 48: 190-2. PMID 2906852 DOI: 10.1159/000132623 |
0.518 |
|
| Show low-probability matches. |
